Sreemannarayana Murali Krishna Pasumarthi

Sreemannarayana Murali Krishna Pasumarthi

Active Director Managing Director DIN 03504778
DIN 03504778 First appointment Sep 2015 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Past companies 1 historical roles
Total affiliations 8 Since Sep 2015
Shareholding value •••• Premium profile

About Sreemannarayana Murali Krishna Pasumarthi

Data last updated:

Sreemannarayana Murali Krishna Pasumarthi is a Managing Director at Intron Life Sciences Private Limited (since 2018), Whole-Time Director at Exome Life Sciences Private Limited (since 2017) and Director at Biome Biologicals Private Limited (since 2021), and holds 4 more current directorships. The companies operate in Life Sciences, Business Outsourcing and Hospitality & Wellness. The 6 current companies with reported revenue have a combined latest revenue of ₹151 Cr; the largest is Intron Life Sciences Private Limited at ₹103 Cr (FY 2025). Earlier, Sreemannarayana Murali Krishna Pasumarthi was a Director at Convergent Biosystems Private Limited (from 2021).

DIN 03504778
Primary Designation Managing Director
Industry Life Sciences
First Appointment 04 Sep 2015
Oldest Company Age 11 yrs
Largest company Intron Life Sciences Private Limited · ₹103 Cr (FY 2025)
Combined revenue ₹151 Cr across 6 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Intron Life Sciences Private Limited U24299AP2018PTC109365
Managing Director28 Sep 20182018₹103 Cr (FY 2025)Active
Exome Life Sciences Private Limited U24304TG2017PTC116405
Whole-Time Director07 Apr 20172017₹27.22 Cr (FY 2023)Active
Biome Biologicals Private Limited U24299TG2021PTC147890
Director20 Jan 20212021₹11.68 Cr (FY 2023)Active
Ipi India Private Limited U24304TG2016PTC113282
Director06 Dec 20162016₹5.77 Cr (FY 2025)Active
Purplecow Foods Private Limited U15122TG2015PTC100561
Director04 Sep 20152015₹3.52 Cr (FY 2024)Active
Kph Infotech Private Limited U72900TG2020PTC144089
Director21 Sep 20202020₹3,600 (FY 2024)Active
Director28 Dec 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Nov 20212021Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Convergent Biosystems Private Limited
Purplecow Foods Private Limited
Intron Life Sciences Private Limited
Biome Biologicals Private Limited
Premium access

Shareholding and investment profile for Sreemannarayana Murali Krishna Pasumarthi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sreemannarayana Murali Krishna Pasumarthi

Sreemannarayana Murali Krishna Pasumarthi currently holds 7 directorships: Intron Life Sciences Private Limited (Managing Director, since 28 Sep 2018, revenue ₹103 Cr (FY 2025)); Exome Life Sciences Private Limited (Whole-Time Director, since 07 Apr 2017, revenue ₹27.22 Cr (FY 2023)); Biome Biologicals Private Limited (Director, since 20 Jan 2021, revenue ₹11.68 Cr (FY 2023)); Ipi India Private Limited (Director, since 06 Dec 2016, revenue ₹5.77 Cr (FY 2025)); Purplecow Foods Private Limited (Director, since 04 Sep 2015, revenue ₹3.52 Cr (FY 2024)); and 2 more.

Sreemannarayana Murali Krishna Pasumarthi was first appointed on 04 Sep 2015 as Director at Purplecow Foods Private Limited. The most recent appointment on record is 28 Dec 2023 at Magma & Flowra Skin Care Private Limited.

The 6 current companies of Sreemannarayana Murali Krishna Pasumarthi that report revenue have a combined latest revenue of ₹151 Cr: Intron Life Sciences Private Limited ₹103 Cr (FY 2025); Exome Life Sciences Private Limited ₹27.22 Cr (FY 2023); Biome Biologicals Private Limited ₹11.68 Cr (FY 2023); Ipi India Private Limited ₹5.77 Cr (FY 2025); Purplecow Foods Private Limited ₹3.52 Cr (FY 2024); and 1 more.

Sreemannarayana Murali Krishna Pasumarthi held 1 earlier board appointment: Convergent Biosystems Private Limited (Director, from 08 Nov 2021).

The current boards of Sreemannarayana Murali Krishna Pasumarthi's companies include Manish Gupta (Intron Life Sciences Private Limited), Pavan Kumar Velpuri (Intron Life Sciences Private Limited), Ronak Modi (Intron Life Sciences Private Limited), Saranya Mukul Agrawal (Intron Life Sciences Private Limited), Vijay Ramvallabh Khetan (Intron Life Sciences Private Limited), Honey Lahoti (Exome Life Sciences Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available